(CTXR) Citius Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Citius Pharmaceuticals | (CTXR) share price targets
Complete technical analysis of Citius Pharmaceuticals (CTXR) by charts plus indicators, forecast predictions and share price targets for Citius Pharmaceuticals (CTXR)
Citius Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2025-02-13 View latest technical analysis
10 day averaged volume of Citius Pharmaceuticals is 71350
| Date | Daily Closing Price | Open | High | Low | Volume |
| 13 Thu Feb 2025 | 2.70 | 2.68 | 2.85 | 2.58 | 1.465 times |
| 12 Wed Feb 2025 | 2.62 | 2.62 | 2.68 | 2.55 | 0.57 times |
| 11 Tue Feb 2025 | 2.63 | 2.67 | 2.73 | 2.55 | 0.712 times |
| 10 Mon Feb 2025 | 2.70 | 2.67 | 2.84 | 2.58 | 1.33 times |
| 07 Fri Feb 2025 | 2.67 | 2.65 | 2.75 | 2.58 | 0.757 times |
| 06 Thu Feb 2025 | 2.65 | 2.67 | 2.69 | 2.51 | 1.424 times |
| 05 Wed Feb 2025 | 2.65 | 2.62 | 2.65 | 2.50 | 0.795 times |
| 04 Tue Feb 2025 | 2.59 | 2.69 | 2.70 | 2.51 | 1.053 times |
| 03 Mon Feb 2025 | 2.69 | 2.65 | 2.74 | 2.60 | 0.711 times |
| 31 Fri Jan 2025 | 2.69 | 2.79 | 2.83 | 2.65 | 1.231 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 2.6 as stoploss in an intra day buy trade for a target of 2.88. However, stock will show a bearish move below 2.6.
Share price targets for Citius Pharmaceuticals (CTXR)
| Target Type | Value |
| Downside Target | 0.11 |
| Downside Target | 0.33 |
| Downside Target | 0.51 |
| Downside Target | 2.44 |
| Downside Target | 2.50 |
| Downside Target | 2.55 |
| Upside Target | 2.75 |
| Upside Target | 2.85 |
| Upside Target | 3.00 |
| Upside Target | 3.13 |
| Upside Target | 3.31 |
| Upside Target | 3.40 |
| Upside Target | 4.25 |
| Upside Target | 4.43 |
| Upside Target | 5.95 |
Intraday share price targets for Citius Pharmaceuticals (CTXR)
| Target Type | Value |
| Downside Intraday Target | 2.55 |
| Downside Intraday Target | 2.4 |
| Upside Intraday Target | 2.85 |
| Upside Intraday Target | 3 |
| Upside Intraday Target | 2.7 |
Weekly technical analysis of Citius Pharmaceuticals (CTXR)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 13 Thu Feb 2025 | 2.70 | 2.67 | 2.85 | 2.55 | 0.86 times |
| 07 Fri Feb 2025 | 2.67 | 2.65 | 2.75 | 2.50 | 0.669 times |
| 31 Fri Jan 2025 | 2.69 | 3.27 | 3.35 | 2.60 | 1.428 times |
| 24 Fri Jan 2025 | 3.30 | 3.25 | 3.40 | 3.00 | 4.507 times |
| 17 Fri Jan 2025 | 3.30 | 3.28 | 3.31 | 3.13 | 0.161 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Citius Pharmaceuticals (CTXR)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 13 Thu Feb 2025 | 2.70 | 2.65 | 2.85 | 2.50 | 0.245 times |
| 31 Fri Jan 2025 | 2.69 | 3.95 | 4.43 | 2.60 | 0.838 times |
| 31 Tue Dec 2024 | 4.00 | 3.54 | 5.95 | 2.44 | 0.014 times |
| 26 Tue Nov 2024 | 4.15 | 0.37 | 4.25 | 0.11 | 11.075 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Citius Pharmaceuticals (CTXR)
Price action analysis of Citius Pharmaceuticals ( (CTXR) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Citius Pharmaceuticals ( (CTXR) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Citius Pharmaceuticals ( (CTXR) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Citius Pharmaceuticals ( (CTXR) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Citius Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Citius Pharmaceuticals in short term and the sell signal is strong.
Citius Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Citius Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Citius Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.66 and Citius Pharmaceuticals (CTXR) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Citius Pharmaceuticals (CTXR) stock. Volume based technical analysis of Citius Pharmaceuticals (CTXR) stock is negative.
Citius Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Citius Pharmaceuticals ( (CTXR) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Citius Pharmaceuticals ( (CTXR) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Citius Pharmaceuticals ( (CTXR) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Citius Pharmaceuticals ( (CTXR) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Citius Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Citius Pharmaceuticals in short term and the sell signal is strong.
Citius Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Citius Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Citius Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.66 and Citius Pharmaceuticals (CTXR) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Citius Pharmaceuticals (CTXR) stock. Volume based technical analysis of Citius Pharmaceuticals (CTXR) stock is negative.
Citius Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.